Center for Vulnerable Populations

Research at ZSFG shows cost savings with rapid TB testing strategy

Results from a study at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) published in JAMA Internal Medicine showed that rapid molecular testing yielded cost savings greater than $13,000 per isolated tuberculosis (TB)-negative patient. By implementing a rapid testing strategy, patients who tested negative were able to discontinue respiratory isolation in significantly less time than in the pre-implementation period.

STEP UP Grand Rounds

In San Francisco, the black population is significantly less healthy than other groups in the city; this community is also disproportionately impoverished.  Medical practitioners are often taught that both race and class are important determinants of health outcomes, however we are not often taught about why this is the case.  Come hear one physician's perspective on how American policies have created a crisis of Black poverty and ill-health in our city.